1.
Lawrence, M.S., et al., Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature, 2013. 499(7457): p. 214-218.
2.
Alexandrov, L.B., et al., Signatures of mutational processes in human cancer. Nature, 2013. 500(7463): p. 415-21.
3.
Witte, T., C. Plass, and C. Gerhauser, Pan-cancer patterns of DNA methylation. Genome Med, 2014. 6(8): p. 66.
4.
Yoshihara, K., et al., Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun, 2013. 4: p. 2612.
5.
Jacobsen, A., et al., Analysis of microRNA-target interactions across diverse cancer types. Nat Struct Mol Biol, 2013. 20(11): p. 1325-32.
6.
Gentles, A.J., et al., The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med, 2015. 21(8): p. 938-945.
7.
Akbani, R., et al., A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun, 2014. 5: p. 3887.
8.
Feil, R. and M.F. Fraga, Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet, 2012. 13(2): p. 97-109.
9.
Keil, K.P. and P.J. Lein, DNA methylation: a mechanism linking environmental chemical exposures to risk of autism
spectrum disorders? Environ Epigenet, 2016. 2(1).
10.
LaSalle, J.M., Epigenomic strategies at the interface of genetic and environmental risk factors for
autism. J Hum Genet, 2013. 58(7): p. 396-401.
11.
Kilpinen, H. and E.T. Dermitzakis, Genetic and epigenetic contribution to complex traits. Hum Mol Genet, 2012. 21(R1): p. R24-8.
12.
Sutter, D. and W. Doerfler, Methylation of integrated adenovirus type 12 DNA sequences in transformed cells is
inversely correlated with viral gene expression. Proc Natl Acad Sci U S A, 1980. 77(1): p. 253-6.
13.
Razin, A. and H. Cedar, DNA methylation and gene expression. Microbiol Rev, 1991. 55(3): p. 451-8.
14.
Moore, L.D., T. Le, and G. Fan, DNA methylation and its basic function. Neuropsychopharmacology, 2013. 38(1): p. 23-38.
15.
Baylin, S.B. and P.A. Jones, A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer, 2011. 11(10): p. 726-34.
16.
Esteller, M., Epigenetics in cancer. N Engl J Med, 2008. 358(11): p. 1148-59.
17.
Esteller, M., Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet, 2007. 16 Spec No 1: p. R50-9.
18.
Klutstein, M., et al., DNA Methylation in Cancer and Aging. Cancer Res, 2016. 76(12): p. 3446-50.
19.
Herman, J.G., et al., Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A, 1994. 91(21): p. 9700-4.
20.
Carmona, F.J., et al., DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev Res (Phila), 2013. 6(7): p. 656-65.
21.
Kolbe, D.L., et al., Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype. PLoS One, 2012. 7(3): p. e32941.
22.
Castelo-Branco, P., et al., Methylation of the TERT promoter and risk stratification of childhood brain tumours:
an integrative genomic and molecular study. Lancet Oncol, 2013. 14(6): p. 534-42.
23.
Bert, S.A., et al., Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell, 2013. 23(1): p. 9-22.
24.
Stefansson, O.A. and M. Esteller, Epigenetic modifications in breast cancer and their role in personalized medicine. Am J Pathol, 2013. 183(4): p. 1052-1063.
25.
Chatterjee, R. and C. Vinson, CpG methylation recruits sequence specific transcription factors essential for tissue
specific gene expression. Biochim Biophys Acta, 2012. 1819(7): p. 763-70.
26.
Jones, P.A., Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet, 2012. 13(7): p. 484-92.
27.
Zhang, W., et al., Predicting genome-wide DNA methylation using methylation marks, genomic position,
and DNA regulatory elements. Genome Biol, 2015. 16: p. 14.
28.
Jones, P.A. and S.B. Baylin, The epigenomics of cancer. Cell, 2007. 128(4): p. 683-92.
29.
Li, E. and Y. Zhang, DNA methylation in mammals. Cold Spring Harb Perspect Biol, 2014. 6(5): p. a019133.
30.
Huang da, W., B.T. Sherman, and R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics
resources. Nat Protoc, 2009. 4(1): p. 44-57.
31.
Huang da, W., B.T. Sherman, and R.A. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis
of large gene lists. Nucleic Acids Res, 2009. 37(1): p. 1-13.
32.
Smoot, M.E., et al., Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics, 2011. 27(3): p. 431-2.
33.
Merico, D., et al., Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One, 2010. 5(11): p. e13984.
34.
Chu, S., H. Wang, and M. Yu, A putative molecular network associated with colon cancer metastasis constructed from
microarray data. World J Surg Oncol, 2017. 15(1): p. 115.
35.
Baier, P.K., et al., Chemokines in human colorectal carcinoma. Anticancer Res, 2005. 25(5): p. 3581-4.
36.
Yang, S.K., et al., Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon
epithelial cells. Gastroenterology, 1997. 113(4): p. 1214-23.
37.
Li, Y., et al., Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell
carcinoma. PLoS One, 2013. 8(4): p. e60027.
38.
Qin, Y.R., et al., Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22
and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. Int J Cancer, 2008. 123(4): p. 826-30.
39.
Gibson, M.K., et al., Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor
in a rat model of gastroesophageal reflux disease. Ann Surg, 2013. 258(1): p. 82-8.
40.
Yang, L., et al., Identification of signature genes for detecting hedgehog pathway activation in esophageal
cancer. Pathol Oncol Res, 2011. 17(2): p. 387-91.
41.
Kebenko, M., et al., ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma:
identification of novel targets for concerted therapy concepts. Cell Signal, 2015. 27(2): p. 373-81.
42.
Li, J., et al., Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent
way in association with the interleukin-23 receptor. Carcinogenesis, 2013. 34(3): p. 658-66.
43.
Portela, A. and M. Esteller, Epigenetic modifications and human disease. Nat Biotechnol, 2010. 28(10): p. 1057-68.
44.
Costa-Pinheiro, P., et al., Diagnostic and prognostic epigenetic biomarkers in cancer. Epigenomics, 2015. 7(6): p. 1003-15.
45.
Miozzo, M., V. Vaira, and S.M. Sirchia, Epigenetic alterations in cancer and personalized cancer treatment. Future Oncol, 2015. 11(2): p. 333-48.